Epilepsy affects 65 million people.
Image is not available

Up to one percent of all people suffer from epilepsy, ten percent have a seizure once in a lifetime.



Epilepsy is one of the most common and serious brain diseases. Epilepsy is a neurological disorder that leads to a permanent tendency to epileptic seizures. These seizures lead to a temporary behavioural disorder. With visanox for the correct diagnosis of epilepsy!

Symptoms, epidemiology & course of epilepsy

Epileptic seizures lead to a temporary behavioural disorder. However, the manifestations and types of seizures can vary. A seizure can lead to unconsciousness, physical numbness or convulsions. According to current research, genetics, immune and infection causes are decisive for an outbreak of epilepsy. For example, more than 500 genes have already been identified that can be linked to epilepsy. In addition, epilepsy often occurs due to brain damage caused by other diseases. Examples include brain tumours, strokes, alcohol abuse and meningitis.

A total of about 65 million people worldwide are affected by the neurological disorder. If the epidemiology of epilepsy is examined in detail, no significant gender differences were found. Thus, people of both sexes suffered from epilepsy about the same frequency. The different types of epilepsy sometimes lead to greatly reduced life expectancy. For example, patients with cryptogenic epilepsy had a reduced life expectancy of two years. In symptomatic epilepsy, a reduction of up to ten years was observed. If one considers the intensity of the epileptic seizures and the possible reduction in the life expectancy of patients with epilepsy, one becomes aware of the psychological strain associated with the disease. In addition, there is little social education about the disease. As a result, there is discrimination, social stigmatisation and misunderstandings in the lives of patients.

Diagnose & Visanox

The correct diagnosis is central in the case of epilepsy. Errors in diagnosis are still common today, leading to incorrect treatment of patients. In a large-scale study, an error rate in diagnosis of 23% was found in England. These can have serious consequences. Some epilepsy diagnoses after a seizure, for example, can be traced back to a disorder of the heart or metabolism and urgently need to be treated differently from epilepsy. Mal-treatment of cardiac arrhythmias can be life-threatening for the patient. This current, error-prone diagnostic process takes into account both the patient’s medical history and physical characteristics.


Visanox offers a completely new procedure for the diagnosis of epilepsy. The brain activities of the patients, which are determined by an EEG, are examined for disease patterns by so-called deeplearning methods. Currently, the error rate in the diagnosis of epilepsy in clinical everyday life is in part over 20% – which can be life-threatening depending on the trigger of the seizure. The visanox software directly examines the organ affected by epilepsy. The activities of the brain provide information about a possible disease – the diagnostic accuracy of visanox is over 95%. An examination and possible diagnosis can therefore be carried out within a few hours.


rapid diagnosis

The software generates a detailed report within a few minutes. With this new information, doctors can be supported in their rapid diagnosis.

long-term nature

visanox offers the possibility of long-term care for your patients. In this way, risk patients can be examined cyclically for the outbreak of disease. The collected data can be stored anonymously and protected on our servers.

diagnostic accuracy

The diagnostic accuracy of the software is over 95%. Combined with the observations of the physician, it is therefore possible to diagnose with almost 100% accuracy and quickly.


The software was perfectly adapted to everyday clinical use. The ease of use avoids errors. The intuitive operability also saves valuable time. Simple, fast, efficient.

With visanox for correct diagnosis

Close Menu